Emergency department-initiated buprenorphine and validation network trial (CTN-0099). 08/15/2023 - 10/18/2024. N01DA-22-2253. Task order 75N95023F00007 (TO11).
Ended Awarded Last action
- Contract number
- 75N95023F00007
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $446,904
Award facts
- Opportunity
-
- 75N95023F00007 Solicitation number
- Contract value 100% obligated
- $446,904.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $147,495 | |
| Original award | $299,409 |
About this award
This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency, to The Emmes Company LLC, a for-profit limited liability company, for the "EMERGENCY DEPARTMENT-INITIATED BUPRENORPHINE AND VALIDATION NETWORK TRIAL (CTN-0099)". The award has a ceiling value of $446,904.00 and covers the period from August 15, 2023 to October 18, 2024, with a final completion date of May 25, 2025. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing type and is not set aside for any specific business category.
The Emmes Company LLC is an established federal contractor that provides a wide range of clinical research and support services to NIDA and other NIH institutes, including data management, statistical analysis, and operational oversight for clinical trials and research programs. This award is connected to NIDA's DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER, which Emmes has held a contract for under a larger Indefinite Delivery Vehicle (IDV) valued at $31 million.
Quick answers
Who was awarded contract 75N95023F00007?
75N95023F00007 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on August 15, 2023.
How much is contract 75N95023F00007 worth?
The government has obligated $446,904 on 75N95023F00007.
Is contract 75N95023F00007 an order under another contract?
Yes. 75N95023F00007 is a delivery order under 75N95022D00017, an indefinite delivery contract.
Was contract 75N95023F00007 competed?
The extent of competition for 75N95023F00007 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award